TRG represents an industry-leading single-source solution for prescription to non-prescription (Rx to OTC) switches* and for retail launches for new OTC products that require a true turnkey solution from design through delivery.
TRG makes it easy for clients to plan and deliver programs under a strict umbrella of compliance for Over-the-Counter (OTC) design through fulfillment. Our speed to market is an industry benchmark. Our adherence to our clients’ Standard Operating Procedures (SOPs) and our strict adherence to current Good Manufacturing Practices (GMPs) ensure that your projects have a safe and quick trajectory to be in store, on time.
Whether you already have a temporary display program ready or are starting from scratch need assistance, we can help.
As the industry-leading provider of multi-branded OTC programs to retailers, TRG has the size and scale to inventory, stage, design, build and deliver multi-branded programs faster and more accurately than other organizations.
Strict GMP’s and SOP’s incorporating CPG-specific guidelines for brands
ISO 9001:2015, FDA registered
Five U.S. locations for OTC fulfillment
Strict mapping and in-out procedures for managing client products
Enterprise-wide ERP software; custom on-line customer portal
ISTA standards and customer-supplied testing standards; in-house ISTA lab
Timelines are not stable or predictable. We know that ‘tweaks’ to a program are inevitable; change and issues occur. Clients require and deserve a flexible, organized partner in this category. That said we are proud to be able to offer our clients industry-leading timelines.
Include EDI, ERP and bar coding
Hand assembly, display assembly, pouching, bagging, shrink wrapping, kitting, inspections, rework, label printing (auto and manual)
[i] Pharma marketing and sales: When to make an Rx to OTC switch. Eye for Pharma. Jan 24, 2012.
[ii] Maximizing Rx-to-OTC Switch Potential. IMS Health. 2010. http://imshealth.com/deployedfiles/imshealth/Global/Content/Consumer%20Health/Static%20Files/RX_OTC_Switch_Flyer.pdf
[iii] New Francesco International Report Reveals $30 Billion of Fresh Opportunities for Rx-to-OTC Switch. Feb 10, 2013. http://www.pr.com/press-release/471785
We’re able to provide FDA-approved plastic packaging that is sterile or static-shielding for medical device shipments. We also offer a vast array of equipment specifically designed for the medical packaging category.